We found 5 mohs skin cancer surgeons who accept Tufts Health Plan near Wellesley, MA.

Showing 1-5 of 5
Selecting one of the sort options will cause this page to reload and list providers by the selected sort order.
Dr. Helen A Raynham, PhD, MD
Specializes in MOHS-Micrographic Surgery
154 East Central Street; 3rd Floor
Natick, MA
 

Dr. Helen Raynham is a mohs skin cancer surgeon in Chelmsford, MA and Natick, MA. In Dr. Raynham's practice, she is particularly interested in mohs surgery. Her patients gave her an average rating of 3.0 out of 5 stars. She is an in-network provider for Fallon Community Health Plan (FCHP), Neighborhood Health Plan, and Cigna, in addition to other insurance carriers. She studied medicine at the University of Cape Town Faculty of Health Sciences. Her medical residency was performed at Brigham and Women's Hospital, Tufts Medical Center, and Boston Medical Center. Dr. Raynham has received professional recognition including the following: Rhodes Scholarship, Oxford University, 1991-4 and D.Phil. Oxford University England. Her professional affiliations include Emerson Hospital, Lowell General Hospital, and Mount Auburn Hospital. Dr. Raynham is open to new patients.

Read more

Clinical interests: Mohs Surgery, Skin Cancer Surgery

Dr. Christine Marie Hayes, MD
Specializes in MOHS-Micrographic Surgery
49 Walnut Park; #4
Wellesley, MA
 

Dr. Christine Hayes is a MOHS-micrographic surgery specialist. She accepts Fallon Community Health Plan (FCHP), Cigna, and Aetna, in addition to other insurance carriers. Dr. Hayes's education and training includes medical school at the University of Michigan Medical School and residency at a hospital affiliated with Case Western Reserve University. In addition to English, she speaks Spanish. She is professionally affiliated with Emerson Hospital, Lowell General Hospital, and Mount Auburn Hospital. Her practice is open to new patients.

Read more
Dr. Carin Litani, MD
Specializes in MOHS-Micrographic Surgery
65 Walnut Street; Suite 480
Wellesley, MA
 

Dr. Carin Litani's specialty is MOHS-micrographic surgery. Dr. Litani's areas of expertise include rosacea, dermabrasion, and acne. She is in-network for Blue Cross/Blue Shield, Cigna, and Medicare, as well as other insurance carriers. After completing medical school at Albany Medical College, she performed her residency at John Stroger Hospital of Cook County. Dr. Litani has received the distinction of Alpha Omega Alpha society. She offers interpreting services for her patients. She is professionally affiliated with Newton-Wellesley Hospital. She has an open panel.

Read more

Clinical interests: Dermabrasion, Botox Injection, Dysport Injection, CO2 Laser Treatment, Laser Resurfacing, ... (Read more)

Specializes in MOHS-Micrographic Surgery
332 Washington Street; Suite 355
Wellesley, MA
 

Dr. Steven Smith is a mohs skin cancer surgeon. Dr. Smith (or staff) speaks the following languages: Hebrew and Mandarin. His professional affiliations include Norwood Hospital, Beth Israel Deaconess (BID) Hospital-Milton, and Newton-Wellesley Hospital. His education and training includes medical school at Tufts University School of Medicine and residency at Tufts Medical Center and Boston Medical Center. Patients gave him an average rating of 4.5 stars out of 5. He takes Cigna, Aetna, and Medicare, in addition to other insurance carriers. Dr. Smith is accepting new patients.

Read more
Dr. Gary Wayne Mendese, MD
Specializes in MOHS-Micrographic Surgery
1 Washington Street; Suite 401
Wellesley, MA
 

Dr. Gary Mendese specializes in MOHS-micrographic surgery. He is in-network for Neighborhood Health Plan, Cigna, and Aetna, in addition to other insurance carriers. He graduated from the University of Massachusetts Medical School and then he performed his residency at Boston Medical Center. Dr. Mendese is affiliated with Winchester Hospital, Lawrence Memorial Hospital, and Melrose-Wakefield Hospital. Dr. Mendese is open to new patients.

Read more

Conditions / Treatments

Gender

Insurance

Medicare Patient Age

Medicare Patient Conditions

Medicare Patient Ethnicity

Medicare Patient Insurance Eligibility

Additional Information

Distinctions

Foreign Language

Research

Online Communication

Practice Affiliation

Credentials

Medical School

Residency

Years Since Graduation

What is MOHS-Micrographic Surgery?

Mohs micrographic surgery is a surgical treatment for skin cancer that was developed by Dr. Frederick Mohs in the 1930’s. It is the most effective technique for removing the most common types of skin cancer. For the two most common types of skin cancer, basal cell carcinoma and squamous cell carcinoma, Mohs has a 98-99% cure rate. The remarkable thing about Mohs is that it manages to be extremely good at removing all of the cancer cells while at the same time leaving behind most of the healthy tissue, so there is a smaller wound. This makes the procedure safer, speeds up the the recovery time, and minimizes scarring.

During Mohs surgery, skin around the cancer site is mapped out and removed in thin layers. Then each layer is examined under a microscope for cancer cells, while the surgery is in progress. If cancer cells are detected, the surgery continues and another layer is removed. If the skin is clear, the surgery can be stopped. This eliminates the guesswork for surgeons. There is no need to estimate the borders or roots of the cancer and no need to remove a margin of healthy tissue to ensure that all of the cancer is removed.

Even though Mohs has a high cure rate, is safer than other treatments, and takes less tissue, not every skin cancer is treated with Mohs. First, Mohs takes quite a bit longer than traditional surgery because each layer of skin must be carefully cut, prepped, and examined. It is also more expensive and may not always be covered by insurance. In addition, for smaller or less aggressive cancers that are easier to treat, the cure rate for non-Mohs treatments is close to that of Mohs; thus, the extra time and cost of Mohs might not be justified. Other kinds of skin cancer, such as melanoma, are hard to see under a microscope. Since melanoma is so dangerous, Mohs has traditionally not been used to treat it, as there is too much risk for missed cancer cells being left behind in the body. However, recent developments in stains (which make cancer cells more visible under a microscope) may change the role of Mohs in melanoma treatment.

Mohs microsurgery has changed the way doctors treat skin cancer in the past 80 years, and it continues to gain in popularity as it increases the effectiveness and safety of skin cancer treatment.
Selecting a checkbox option will refresh the page.